Featured Editor

Published over 160 journal articles, book chapters, conference papers, patents and reports

Dr Fee，新西兰Canterbury大学化学工程系教授，主攻生物工程、生物化学与生物分子工程。博士研究课题是颈动脉中的血流干扰以及与动脉粥样硬化的联系。在加拿大Waterloo大学1989/90届的博士后研究生期间，从事超滤膜研究，回到新西兰后，在Waikato大学担任讲师，同时任新西兰肉类食品研究院生物化学工程员。从1996年开始，一直担任新西兰Waikat大学的全职讲师，2003年—2006年任材料和工艺工程系主任，期间曾担任Canterbur大学化学工程系主任。在蛋白质纯化、蛋白质PEGylation、膜分离和过程色谱法领域拥有丰富经验，一直从事控制药物释放、微囊法和高价值乳蛋白质纯化的研究。现任Canterbury大学生物分子交互作用研究中心主任，专注于表面等离子共振技术领域的研究。发表了160多篇化学工程学术期刊文章、专书论文、研讨会论文、专利与行业研究报告。2008年开始在理文编辑担任化学工程和生物工程编辑。

Dr Fee is a professor of chemical engineering at the University of Canterbury, with expertise particularly in biotechnology, biochemical and biomolecular engineering. His PhD topic was on blood flow disturbances in the carotid artery and their links to atherosclerosis. He was a post-doctoral fellow at the University of Waterloo, Canada, in 1989/90, working on membrane ultrafiltration. He then returned to NZ as a lecturer at the University of Waikato, and a biochemical engineer at the Meat Industry Research Institute of New Zealand (MIRINZ). A full-time lecturer at the University of Waikato from 1996, he was head of the Department of Materials and Process Engineering from 2003 until 2006, when he took up a chair in chemical engineering at the University of Canterbury. Dr Fee has a wide range of experience in protein purification, protein PEGylation, membrane separations and process chromatography, and has worked in controlled drug delivery, microencapsulation and high-value dairy protein purifications. He is Director of the Biomolecular Interactions Centre at the University of Canterbury and has expertise in surface plasmon resonance. Dr Fee has published over 160 journal articles, book chapters, conference papers, patents and industrial research reports across a wide range of chemical engineering topics. Dr Fee began working with Edanz Editing as an editor in fields associated with chemical engineering and biotechnology in 2008.

Dr. Devon 是一名生物学家，致力于神经系统科学和遗传学。她于1996年取得了精神疾病遗传学的博士学位。随后在加拿大温哥华以及英国的爱丁堡开始了博士后的深造，主要研究运动神经元疾病 (Lou Gehrig's Disease，洛盖赫里格病 ) 的一种罕见遗传形式。她著有50余篇研究论文、专书论文、评论和经费申请，曾为分子生物学期刊审稿。Dr. Devon 从2008年起为理文编辑工作。

Dr Devon is a biologist with a special interest in neuroscience and genetics. She is a graduate of the University of Cambridge, United Kingdom, and obtained her PhD in 1996 from the University of Edinburgh, UK, in the genetics of psychiatric illness. She undertook post-doctoral research on a rare, inherited form of Motor Neurone Disease (Lou Gehrig's Disease) in Vancouver, Canada, and then started her own research group back in Edinburgh, UK, investigating the genetics, cell biology and biochemistry of motor neurone disease. She is a co-founder of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Dr Devon has written over 50 research papers, book chapters, reviews and successful grant applications, and has peer-reviewed manuscripts for molecular biology journals. Dr Devon began working with Edanz Editing in 2008.

Featured Editor

Formerly a specialist Medical Indexer at Thomson Scientific

Dr Furness在格拉斯哥Beatson癌症研究院从事三年的博士后研究，此期间，利用分子遗传学技术对与癌症（如白血病）发展有关、影响造血干细胞生长的因素进行研究。后任格拉斯哥大学研究员，通过实地观察、放射同位素血液样分析和对海鸟代谢监测，分析海鸟的能量需求。Dr Furness是一位知识渊博的科技编辑，拥有大量的科技论文提炼、索引和编辑经验，涉及的领域包括通用医学、药学和遗传学，在科研实践和发表研究论文方面拥有丰富的个人经历。1993-2007年期间，在Thomson Scientific从事专家医学文摘工作，2007年起为理文编辑工作。

For three years, Dr Furness was a Post-doctoral Research Fellow at the Beatson Institute for Cancer Research, Glasgow, where she used extensive molecular genetic techniques to examine the factors influencing the growth of hematopoietic stem cells, with relevance to the development of cancers such as leukemia. Later Dr Furness was a researcher at Glasgow University where she analyzed the energetic requirements of seabirds, using field observations, analysis of radioisotopes from blood samples and metabolic monitoring of birds in respirometers. Dr Furness is a scientific editor with extensive experience of abstracting, indexing and editing scientific papers on a wide range of topics including general medicine, pharmacology and genetics, with personal experience of active scientific research and the publishing of research papers. From 1993 to 2007, Dr Furness was a Specialist Medical Indexer at Thomson Scientific. She began working with Edanz Editing in 2007.

McPherson拥有化学专业背景。博士研究课题是“铂和钯的硫取代烷基配合物”，曾对硫取代有机铂和有机钯配合物的合成和属性进行研究调。拥有25年的科学论文发表经验，主要涉及物理科学和工程领域。2002年以来，一直是独立撰稿人和编辑顾问，2009年开始为理文编辑工作。

McPherson's background is in chemistry. For her PhD, “Sulfur-substituted alkyl complexes of platinum and palladium,” she investigated the synthesis and properties of sulfur-substituted organoplatinum and organopalladium complexes. She has over 25 years' experience in scientific publishing, working mainly in the physical sciences and engineering. She has been an independent publishing and editorial consultant since 2002 and began working for the Edanz Group in 2009.

Featured Editor

Did Post-doc at the Scripps Institute; and was a Managing Editor for Elsevier in Oxford

Dr.Mahkdum 曾任 University College London 研究员，后在加利福尼亚州 UCSD Scripps Institute 从事博士后研究工作。从2000年开始，Dr.Mahkdum 一直从事医学写作和编辑工作，担任过多个职务，包括2005年至2007年间牛津 Elsevier的总编辑一职。Dr.Mahkdum 从2008年起开始为理文编辑工作。

Dr Mahkdum was a Research Fellow at the University College London before becoming a Post-doctoral Research Fellow at the Scripps Institute at the University of California, San Diego, in California. Since 2000, Dr Makhdum has been a medical writer and editor holding various positions including Managing Editor at Elsevier in Oxford from 2005 to 2007. Dr Makhdum began as an editor with Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

Dr Potter目前为西澳大利亚州全科医生，博士期间研究用维生素B族干预同型半胱氨酸的效用降低治疗对于中风患者血管结构和机能改善的长期效果。她的博士论文直接得以出版发表。Dr Potter是一位经验丰富的临床医生和研究人员，从2009年起开始为理文编辑工作。

Dr Potter is currently a general practitioner in Western Australia. Dr Potter’s PhD was concerned with the long-term effects of homocysteine-lowering treatment with B vitamins on vascular structure and function in stroke patients. Her thesis was submitted as a publication. Dr Potter, an experienced clinician and researcher, began working with the Edanz Group in 2009.

Featured Editor

Received the MacDiarmid Young Scientist of the Year Award in New Zealand in 2007.

Dr David一直从事多个领域的研究工作，包括无机化学、物理化学和分析化学等。最近的研究工作是调查违禁药物分析中同位素比质谱仪在法医鉴定中的使用。她是一名经验丰富的科学传播者和编辑，2007年在新西兰获MacDiarmid年度青年科学家奖。曾在联合国药物与犯罪办公室实习（曼谷，泰国）。经常出席各种物理、分析和法医化学大会，在同行评审期刊上多次发表文章。于2008年开始为理文编辑工作，担任编辑。

Dr David has conducted research in many areas, including inorganic chemistry, physical chemistry, and analytic chemistry. Her most recent research investigated the forensic use of isotope ratio mass spectrometry for the analysis of illicit drugs. Dr David is an experienced science communicator and editor, and received an award in the MacDiarmid Young Scientist of the Year competition (2007, New Zealand). She has also completed an internship with the United Nations Office on Drugs and Crime (Bangkok, Thailand). Dr David has presented at conferences and has peer-reviewed publications in the areas of physical, analytical, and forensic chemistry. Dr David began working as an editor with the Edanz Group in 2008.

Featured Editor

Specialist editor in the fields of pharmacy practice, drugs and therapeutics

John Kristiansen自1990年以来一直任药剂师。1992-2007年期间，曾在新西兰和英国儿科医院从事临床工作，包括在Starship/Auckland市医院担任7年的儿童健康药剂师主管。儿科临床经验包括：血液学与肿瘤学、实体器官移植、重症护理、呼吸道疾病和全肠外营养。自2007年开始，一直担任用药质量药剂师/项目主管，从事基础卫生保健相关工作。曾负责编写和编辑了各种面向保健专家的培训教材，对倡导安全、有效用药的各种干预活动进行评估。2010年加盟理文编辑，负责配药实践、药物与治疗以及综合健康领域的专业编辑。

John Kristiansen has worked as a pharmacist since 1990. From 1992-2007 he held clinical positions in NZ and UK pediatric hospitals, including seven years as the Children’s Health Pharmacist Team Leader at Starship/Auckland City Hospital. Mr Kristiansen has worked clinically in a range of pediatric sub-specialties: hematology and oncology, solid organ transplantation, intensive care, respiratory disease, and total parenteral nutrition. Since 2007 he has been working as a Quality Use of Medicines Pharmacist/Project Manager for initiatives focused on the primary health care sector. He writes and edits pharmaceutical educational materials for health professionals and evaluates interventions that promote the safe and effective use of medicines. He joined the Edanz Group in 2010 and is a specialist editor in the fields of pharmacy practice, drugs and therapeutics, and allied health fields.

Featured Editor

Expert in Neurobiology and behavior

Dr. Demarest 先后取得了心理学学士和纽约州立石溪大学博士学位。她一直致力于行为小鼠模型的神经系统科学和遗传学的研究。现任 The Scripps Research Institute 科学家。Dr. Demarest 从2008年起加入理文编辑。

Dr Demarest received a BSc in Psychology and a PhD in Neurobiology and Behavior from the State University of New York at Stony Brook. Her work has focused on the neuroscience and genetics of a behavioral mouse model. From her research she has authored several peer-reviewed papers. She is currently a staff scientist at the Scripps Research Institute. She joined the Edanz Group as an editor in 2008.

Featured Editor

Previously worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology

Dr Schade-Bijur的博士学位研究重点是确定人类大脑神经细胞钠离子通道的启动区，研究成果已在神经科学学会的一次国际会议上宣讲，并在同行评审期刊上发表。拥有精湛的高度分子生物学领域技术，包括：克隆、基因、DNA和蛋白质提取、RT - PCR检测、杂交、测序和凝胶电泳。曾在一家生物技术公司工作7年，重点研究神经肿瘤靶向治疗放射肽。作为科学家和高级制造经理，针对各种组织进行了生理组织学实验（包括使用组织切片机备制切片），研究卵母细胞的提取和神经胶质瘤氯离子通道。另外还负责临床药学，是编写基金申请和规范性文件的临床小组成员。发表了基于实践经验的两篇同行评审论文（包括临床试验论文）。作为一名自由撰稿人，其写作领域涉及卫生经济学和医学教育（关于癌细胞血管生成），撰写了50多份脂质产品技术公告。科技写作背景丰富，2010年加盟理文编辑，主要从事神经学和肿瘤领域的撰稿和编辑。

Dr Schade-Bijur’s PhD focused on identifying the promoter region of a neuronal sodium channel in the human brain. Dr Schade-Bijur’s work from these studies has been presented at an international Society of Neuroscience meeting and published in peer-reviewed journals. She is highly skilled in molecular biology techniques, such as cloning, mRNA, DNA and protein extraction, RT-PCR, blotting, sequencing and gel electrophoresis. For seven years Dr Schade-Bijur worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology. As a scientist and the Senior Manager for Manufacturing, Dr Schade-Bijur performed histology experiments for various tissues, including using a microtome for tissue slice preparation, and oocyte extraction and electrophysiology on a glioma chloride channel. Dr Schade-Bijur was also in charge of the clinical pharmacy and was part of the clinical team writing grants and regulatory documents. From this research she published two more peer-reviewed papers, including a clinical trial paper. As a freelance writer, Dr Schade-Bijur has written in the areas of health economics, medical education regarding cancer angiogenesis and over 50 technical bulletins about lipid products. Dr Schade-Bijur has a particularly broad science and writing background. She joined the Edanz Group as a writer and editor in 2010, specializing in the fields of neuroscience and oncology.

Dr Colebrooke的博士研究课题是“帕金森多巴胺大鼠模型的分子、神经生化和行为分析”。之后成为英国Babraham Institute分子神经科学实验室博士后研究员。熟悉各种常用实验室技术、试验和小动物模型。曾多次以第一作者身份在国际期刊杂志上发表文章。2006年开始为理文编辑工作，任编辑一职。

Dr Colebrooke’s PhD title was “Molecular, neurochemical and behavioural analyses of a novel dopamine-depleted mouse model of Parkinson’s disease.” She then was a post-doc research scientist in the Laboratory of Molecular Neuroscience, The Babraham Institute, UK. Dr Colebrooke is familiar with all the usual laboratory techniques and tests, along with small animal models. Dr Colebrooke has several first-authored publications in international journals. She began as an editor with Edanz Editing in 2006.

Featured Editor

Specialist medical writer and endocrinology expert

Dr. Smith 的博士论文标题为：“The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”。 一直担任 Queen Mary, University of London 细胞与分子科学研究所研究助手，并着重于糖尿病及相关代谢疾病的生物化学的研究。同时担任 London Sport Institute 研究员。曾在 London School of Journalism 进修过与出版相关的编辑和设计课程，现为全职医学作者。Dr. Smith 在全球知名机构 Medicus International 任职期间，通过与多家著名制药公司合作的医学交流项目积累了大量的医学和科学交流经验。2006年起加入理文编辑，凭借着广泛的研究背景以及出色的医学写作经验帮助客户达到顺利发表的目标。

Dr Smith’s PhD thesis was entitled “The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”. Dr Smith has been a Research Assistant at the Queen Mary, University of London’s Institute of Cellular and Molecular Sciences, where he focused on the biochemistry of diabetes and related metabolic disorders. He has also been a Research Fellow at the London Sport Institute, part of Middlesex University. Dr Smith has studied editing and design skills in relation to publication at the London School of Journalism, and is now a full-time medical writer. Dr Smith gained extensive experience in medical and scientific communications while employed at the internationally recognized agency Medicus International, where he worked on a range of medical communications projects for several well-known pharmaceutical companies. He joined the Edanz Group in 2006, where he is able to apply his wide research background and expertise in the medical communications sector in assisting clients to achieve their publication goals.

Dr Roth发表的文章涉及以下领域：T细胞生物学、基因重排的分子机制、发育生物学、神经生物学、核受体生物学。在转基因动物模型、开发基因组和蛋白质组技术、运用基因和蛋白质表达谱方法进行疾病诊断和治疗（包括糖尿病、肥胖、血液疾病和肿瘤）等方面拥有丰富经验。联合撰写并在影响力极高的杂志上发表了13篇文章，同时还和专利发明人联合撰写了5篇专利书。曾为知名生物制药、医疗设备和生物科技等公司提供有关平台技术和产品开发方面的顾问建议。多年担任昆尼皮亚克大学客座教授，在线授课生物学本科课程。在美国西北大学期间，获美国癌症学会博士后奖学金；在纽约冷泉港期间，研究发育神经生物学。于2010年开始为理文编辑工作，担任编辑。

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Dr Parker的博士研究领域是癌生物学和信号传导，后在佛罗里达大学射线肿瘤科从事博士后研究。现为New York Journal of Books科技文章审稿人。2010年开始为理文编辑工作，担任医学作者和编辑。

Dr Parker’s PhD studies were in the field of cancer biology and signal transduction. Her post-doctoral research was in the Department of Radiation Oncology at the University of Florida. Dr Parker is presently a science reviewer with the New York Journal of Books. She began working with the Edanz Group as a medical writer and editor in 2010.

Featured Editor

Specialist in the field of hypertension and recipient of the Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Doctoral Award

Dr Komolova的博士课题是论述各种疾病状态下（高血压、盐敏感、肥胖症）肾脏对血压调节的作用。另外，还研究了降压药及生活方式改变对心血管和代谢功能的影响。精通多种研究技术，从分子法到整体动物法。研究成果已发表在科学期刊上，其中包括Hypertension、Journal of Hypertension、International Journal of Obesity。现任女王大学药理学和毒理学系的客座教授兼研究督导，也是自由职业医学作家。2010年起为理文编辑工作。

Dr Komolova’s doctoral dissertation focused on characterizing the role of the kidneys in blood pressure regulation in various disease states (hypertension, salt-sensitivity, and obesity). She also investigated the effects of antihypertensive drugs and lifestyle changes on cardiovascular and metabolic function. She is proficient in numerous research techniques, ranging from molecular to whole-animal methodologies. Her work has been published in scientific journals including Hypertension, the Journal of Hypertension, and the International Journal of Obesity. Currently, she is an Adjunct Professor and Research Facilitator in the Department of Pharmacology & Toxicology at Queen’s University, and a freelance medical writer. Dr Komolova began working with the Edanz Group in 2010.

作为药剂师，Dr. Vocadlo 在生物技术公司从事了六年的药物化学和药品研发工作；曾经参与过化合物多步合成及光谱分析，包括实验设计、操作、化合物的分离、纯化和鉴定等研究工作。他还收集并研究相关信息，向美国新药申请 (NDA) 提交监管意见书。Dr. Vocadlo 发表过第一作者论文，在科技论文写作和编辑方面经验丰富，2007年开始为理文编辑工作。

Dr Vocadlo is a chemist with six years’ experience in medicinal chemistry and drug product development in biotech companies. As a researcher she was involved in multi-step synthesis and spectroscopic analysis of compounds, including experiment planning, execution, compound isolation, purification and identification. Dr Vocadlo has also gathered and evaluated information, and then prepared regulatory submissions for NDA (New Drug Applications of the US FDA). As well as being a published first author, Dr Vocadlo has extensive experience in technical writing and editing (theses, manuscripts, protocols and reports). Dr Vocadlo began working with Edanz Editing in 2007.

Dr. Shoemaker的学术研究领域是药理学和毒理学，着重于神经组织退化疾病、内分泌疾病和肠胃病学的研究。在她的博士研究阶段，她研究并发表了关于肌萎缩病理中的大麻CB2受体的引入。在Emory University攻读博士后期间，她主要研究糖尿病早期肠道神经轴突的病理生理学。Dr. Shoemaker是一位经验丰富的编辑，于2009年起加入理文编辑。

Dr Shoemaker's scientific background is in pharmacology and toxicology with a focus on neurodegenerative diseases, endocrine disorders and gastroenterology. For her PhD, she investigated and published on the involvement of the second cannabinoid receptor (CB2) in the pathology of amyotrophic lateral sclerosis. For her post-doctoral fellowship at Emory University, she studied the pathophysiology of enteric axons during the early stages of diabetes. Dr Shoemaker is an experienced editor and began working for the Edanz Group in early 2009.

Dr Bradshaw是一位在生物医学科学和医疗保健领域有深厚研究功底的临床专家，欧洲医学作家协会成员，发表了17篇科技文章。2007-2008年间，当选为英国皇家内科医院指南开发小组和指导小组成员，负责指导《国家健康服务》指南的发表。还作为第一作者为英国皇家内科医学院撰写了关于“职业视力标准”，作为眼科的全国准则。在数家顶尖期刊从事同行评审工作，其中包括：《美国眼科学杂志》、《航空航天与环境医学》和《英国全科医疗学刊》。Dr Bradshaw 是医疗与生物科学的全面手专家编辑。于2010年加盟理文编辑，担任撰搞人和编辑。

Dr Bradshaw is a clinical specialist with a strong background in biomedical science and healthcare related research. He is a member of the European Medical Writers Association (EMWA), and has published over 17 scientific papers. In 2007/8, Dr Bradshaw sat on the board as an elected member of both the Royal College of Physicians guideline development and steering groups, leading to the publication of National Health Service guidelines. He also first-authored the UK national guidelines on “Occupational Visual Standards” for the Royal College of Ophthalmologists. He is a peer reviewer for several top journals including: the American Journal of Ophthalmology, Aviation Space and Environmental Medicine and the British Journal of General Practice. Dr Bradshaw is a specialist editor across a wide variety of medical and bioscience topics. He joined the Edanz Groups as an editor and writer in 2010.

Featured Editor

Pharmaceuticals and drug research expert

Dr. Mosi 的在博士生阶段主要研究糖基转移酶，包括通过使用改良培养基和抑制剂研究糖原磷酸化酶和环糊精糖基转移酶反应机理。Dr. Mosi 曾在制药研究领域里从事八年的高级研究工作。她进行过将金属酶抑制剂用于抗菌药物以及半胱氨酸蛋白酶抑制剂用于癌症治疗等全新研究。Dr. Mosi在酶学、基于受体的细胞生物学、药物新陈代谢、蛋白纯化和培养生产等领域均有所建树。此外，她还设计并规范了译制学术成果的系统和流程，熟知 FDA条款、GLP和GMP规范。Dr. Mosi是Drug Information Association（药品信息协会）、International Society for the Study of Xenobiotics（国际外源物研究学会）、Society for Biomolecular Screening（生物分子筛选学会）、American Society for Microbiology（美国微生物学会）以及 Canadian Society for Chemistry（加拿大化学会）等组织的正式成员。以第一作者的身份发表过10篇同行评审论文，并编辑过生物学、生物化学、化学以及药理学等领域的诸多文章。

Dr Mosi’s PhD studies involved the mechanism of reaction of two alpha glycosyltransferases, glycogen phosphorylase and cyclodextrin glycosyltransferase, through the use of modified substrates and inhibitors. Dr Mosi is a senior research scientist with eight years’ experience in pharmaceutical drug research. She has developed and implemented novel assays for the purpose of the identification of inhibitors of metallo-enzymes as antibacterials and inhibitors of cysteine proteases for the treatment of cancer. Dr Mosi has applied expertise in enzymology, receptor based cell biology, drug metabolism and protein purification and production. As well, she has designed and standardized systems and procedures for interpreting scientific results. She also has a sound knowledge of FDA guidelines and is trained in GLP and GMP procedures. Dr Mosi is a past member of the Drug Information Association, International Society for the Study of Xenobiotics, Society for Biomolecular Screening, American Society of Microbiology, and the Canadian Society of Chemistry. As first author of 10 published, peer reviewed manuscripts, and as editor of numerous other papers in fields of biology, biochemistry, chemistry and pharmacology, Dr Mosi brings an extensive writing background to her editing work for Edanz Editing.

Dr. Apricó 的博士论文题为“[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters”。2003年至2005年间，Dr. Apricó在瑞典哥德堡大学 Arvid Carlsson Institute 与Dr. Michael Nilsson一起从事博士后研究工作，主要研究反应性星形胶质化的体外模式。2005年后，一直担任大学药理学和生理学的讲师工作，并于2009年年中重返校园攻读医学学位。Dr. Apricó从2008年起开始为理文编辑工作。

Dr Aprico's doctoral thesis was \[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters. From 2003 to 2005 Dr Aprico held a post-doctoral position at Arvid Carlsson Institute Göteborg Sweden working with Dr Michael Nilsson investigating in vitro models of reactive astrogliosis. Since 2005 Dr Aprico has been a university lecturer in pharmacology and physiology but returned to university to obtain her medical degree in mid-2009. Dr Aprico began as an editor with the Edanz Group in 2008.

专业背景为生物化学，重点研究海洋无脊椎动物和哺乳动物皮肤内的脂质生化途径。博士研究方向是通过放射性同位素示踪、结构分析和比较生物化学研究，描述马属动物产生皮脂的生化途径。博士后研究课题是将马皮脂巨环内酯和哺乳动物皮肤表皮防水层联系起来。Dr Colton是一位通才科学家，同时还是大学教授，教授课程包括：无机化学、有机化学、生物化学、分子生物学、核物理学和天文学。多次指导同事和学生撰写论文、报告和学术文章并进行校对。已在在同行评审刊物上发表13篇论文，从2007年开始担任编辑。2009年供职理文编辑，从事编辑工作。

Dr Colton's research background in biochemistry focused on lipid biochemical pathways in marine invertebrates and mammalian skin. His doctoral thesis involved describing the biochemical pathways for sebaceous lipid production in the genus Equus through radio-label, structural analysis, and comparative biochemical studies. His post-doctoral work involved relating the giant ring lactones of equine sebum to the epidermal water barrier of mammalian skin. Dr Colton is a generalist scientist and, as a college professor, taught courses from inorganic and organic chemistry to biochemistry and molecular biology to nuclear physics and astronomy. He has advised and edited numerous theses, papers, and articles for colleagues and students. He has published 13 papers in peer-reviewed journals and has been an active editor since 2007. Dr Colton began editing for the Edanz Group in 2009.

Featured Editor

Neuroendocrinology and tumor biology expert

Dr Cleary是生物医学科学家，专注癌症研究和慢性疾病研究。博士论文题目是“从嗜铬细胞到嗜铬细胞瘤：对交感神经链的探讨”。曾在国家神经疾病和中风研究院（NIH）任博士后研究员，作为首席研究员负责一项转移性肾脏疾病治疗新战略研究的项目。在癌肿瘤生物学和癌症发展起源研究方面积累丰富经验，特别是与von Hippel-Lindau gene抑癌基因突变相关的课题。对卫生政策有浓厚的兴趣，曾在美国国立卫生研究院福格蒂国际中心任研究员。在此期间，参与了多项全球卫生政策项目。在同行评审期刊上发表了大量文章，另外还出版了面向非技术性读者的科技文章。2010年加盟理文，从事编辑工作。

Dr Cleary is a biomedical scientist with a special interest in cancer research and chronic disease. Her doctoral thesis was entitled “From chromaffin cells to phaeochromocytoma: insight into the sympathoadrenal lineage”. Dr Cleary was a Post Doctoral Fellow with the National Institutes of Neurological Disorders and Stroke (NIH), where she was the lead researcher on a project investigating novel strategies for the treatment of metastatic kidney disease. Dr Cleary has an extensive history of research in cancer tumor biology and an interest in the developmental origins of cancer, especially those related to mutations of the von Hippel-Lindau gene. Dr Cleary has an interest in health policy and was a Fellow with the Fogarty International Center at the NIH. During this time she was involved in a number of global health policy projects. Dr Cleary has published a number of articles in peer-reviewed journals in addition to other science writing for a non-technical audience. Dr Cleary began working as an editor for the Edanz Group in 2010.

Dr. de Boo 是一名生理学家，主要研究胎儿生长和新陈代谢。她的博士论文题为“Aspects of Nitrogen Metabolism in Intrauterine Growth Restriction”，主要探讨了发育迟缓的人类新生儿和绵羊胎儿的尿素循环代谢障碍问题。在攻读博士后期间，完成了通过补充荷尔蒙的方法，对胎儿宫内发育迟缓而进行的子宫内治疗的研究。Dr. de Boo 对于写作和编辑学术类和非学术类稿件都具有丰富的经验，现为全职编辑。

Dr de Boo is a physiologist with a particular interest in fetal growth and metabolism. Her PhD thesis was entitled “Aspects of Nitrogen Metabolism in Intrauterine Growth Restriction,” focusing primarily on urea cycle disorders in growth-restricted human neonates and fetal sheep. She has since completed a post-doctoral study on the development of intrauterine treatments for intrauterine growth restriction by hormonal supplementation. Dr de Boo has extensive experience in writing and editing both scientific and non-scientific manuscripts and is now a full-time freelance editor.

职业经历

Dr. Lodge 是一名细胞生物学家，在学术研究领域具有广泛的经验，初期从事制药及干细胞疗法监管事务。博士和博士后就读阶段，他主要研究神经系统发育过程中肌动蛋白细胞骨架和细胞黏附分子对轴突导向的作用。Dr. Lodge 于2001年加入葛兰素史克 (GlaxoSmithKline) 公司，领导神经变性疾病和精神疾病的目标识别和确认工作，以及干细胞相关的药物研发战略的开发。2009年至2011年间，Dr Lodge任伦敦大学学院 (University College London) 干细胞疗法项目负责人，负责根据最新颁布的高级治疗要用产品(ATMPs)指令申请相关证照的工作。他具有广泛的细胞生物、分子生物和蛋白质生化技术等方面的专业技能，在国际同行评审期刊上发表过多篇第一作者文章，对于多种临床前及临床规范性文件的写作经验丰富。Dr. Lodge 目前从事基于细胞的药物研究、ATMP监管事务以及学术写作(包括web开发)方面的咨询工作，从2008年起开始为 Edanz Group 工作。

Dr Lodge is a cell biologist with wide-ranging experience in academic research, early stage drug discovery, and stem cell therapy regulatory affairs. For his PhD and postdoctoral work, Dr Lodge studied the roles of the actin cytoskeleton and cell adhesion molecules in axon guidance during nervous system development. Dr Lodge joined GlaxoSmithKline in 2001, where he held research and programme leadership roles within target validation initiatives for neurodegenerative and psychiatric diseases. He was also involved in developing drug discovery strategies involving stem cells. From 2009 to 2011, Dr Lodge was Programme Manager for a stem cell therapy unit at University College London, where he was responsible for the unit obtaining the necessary licenses required by the recently introduced Advanced Therapy Medicinal Products (ATMPs) directive. His technical expertise covers a broad spectrum of cell biology, molecular biology and protein biochemistry techniques, including their application to drug discovery assay development. Dr Lodge has published several first author publications in international peer-reviewed journals, and he is experienced in writing a variety of pre-clinical and clinical regulatory documents. Dr Lodge currently offers consulting services in cell-based drug discovery, ATMP regulatory affairs, and scientific writing (including web development). He began editing for the Edanz Group in 2008.

坎特伯雷大学高级研究员，自1962年起就在该校授课。发表的著作包括纯图论以及组合优化在作业研究、工程、建筑和医学上的应用，还为知名刊物撰写了有关植物结构的文章。2008年起为理文编辑工作。

Dr Robinson is a Senior Fellow in Mathematics at the University of Canterbury, where he has lectured since 1962. His publications range from pure graph theory to combinatorial optimization with applications to operations research, engineering, architecture and medicine. Dr Robinson has also written in major journals on the architecture of plants. He began working with Edanz Editing in 2008.

英国爱丁堡大学药理学研究员、伦敦大学和牛津大学研究助理、阿伯丁大学生理学讲师。在阿伯丁大学，她还建立了电生理实验室，用以研究药物作用与哺乳动物心室肌细胞电活动的关系。Dr Cant拥有丰富的写作和编辑经验，曾为欧共体Cordis Results and Publications数据库和BEST（英国科技专家）数据库及其在美国的姐妹数据库编辑生物和物理科学类文章。多年任Thomson Scientific医学编辑、数据库编索人，拥有心血管病学、肠胃病学、神经科学、流行病学、药理学和生理学领域的知识背景。

Dr Cant has been a Research Fellow (Pharmacology) at the University of Edinburgh and a Research Assistant at the University of London and the University of Oxford, as well as a Lecturer in Physiology at the University of Aberdeen where she also established an electrophysiology laboratory for investigation of drug effects on electrical activity in isolated mammalian cardiac ventricular cells. Dr Cant also has extensive writing and editing experience, having edited papers in biological and physical sciences for the European Community CORDIS Results and Publications databases, as well as for the BEST (British Expertise in Science and Technology) database and its sister database in the US. Dr Cant was a medical editor/database indexer for Thomson Scientific for a number of years and has a wide knowledge of various areas including cardiovascular disease, gastroenterology, neuroscience, epidemiology, pharmacology and physiology.

Featured Editor

Member of the Society for Neuroscience, the College on Problems of Drug Dependence, and the American Society for Pharmacology and Experimental Therapeutics

生物学家，拥有神经科学和药理学的丰富经验。博士课题是研究MDMA（摇头丸）的体内药理，目前为佐治亚州亚特兰大埃默里大学博士后研究员。研究成果曾获多项荣誉和嘉奖，是神经科学学会、药物依赖问题学院和美国药理学和实验疗法学会会员。目前的研究兴趣包括：通过行为药理学、神经化学和神经影像学技术，对兴奋剂的体内影响进行研究。另外还在抑郁、焦虑、精神分裂、认知、比较心理学、动物行为等领域积累了丰富经验。2010年加盟理文编辑，担任撰稿人和编辑，利用其研究背景和专业知识协助客户实现出版目标。

Dr Murnane is a biologist with particular experience in neuroscience and pharmacology. His PhD dissertation topic was an examination of the in vivo pharmacology of methylenedioxymethamphetamine (MDMA, “ecstasy”). Dr Murnane is currently a post doctoral fellow at Emory University, Atlanta, Georgia, the United States. He has received numerous prestigious honors and awards for his research. Dr Murnane is a member of the Society for Neuroscience, the College on Problems of Drug Dependence, and the American Society for Pharmacology and Experimental Therapeutics. His present research interests include studying the in vivo effects of psychostimulants using behavioral pharmacology, neurochemistry, and neuroimaging techniques. Dr Murnane also has significant experience in the fields of addiction, depression, anxiety, schizophrenia, cognition, comparative psychology, and animal behavior. In 2010 he joined Edanz Group, where he applies his research background and expertise as a writer and editor to assist clients achieve their publication goals.

Dr. Daniel 的博士学位论文题为“Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90”。熟悉各种实验室和研究技巧，包括分子生物学技术、器官培养、永生化细胞系 (哺乳动物) 的组织培养、外源蛋白的重组和纯化、重组DNA、荧光共焦显微术、哺乳动物细胞瞬时转染、定点突变、单/双向凝胶电泳、化验、蛋白质印迹、表面等离子体共 振技术、薄层高压液相色谱法 (HPLC) 等。Dr. Daniel从2008年起加入理文编辑。

Dr Daniel’s PhD thesis was entitled “Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90.” Dr Daniel is familiar with all standard laboratory and research techniques including molecular biological techniques, organ culture, tissue culture of immortalized cell lines (mammalian), recombinant production and purification of heterologous proteins, recombinant DNA manipulation, confocal fluorescent microscopy, transient transfection of mammalian cells, site directed mutagenesis, one- and two-dimensional gel electrophoresis, assay techniques, Western blot analysis and surface plasmon resonance spectroscopy, and thin layer and high pressure liquid chromatography (HPLC). Dr Daniel began as an editor with the Edanz Group in 2008.

原就读格拉斯哥大学微生物学，后去阿伯丁大学疱疹病毒学攻读博士学位。之尔后主攻电子显微镜，又继续了几年超声波治疗癌症的博士后研究，后来又取得信息学文凭，自1991年起从事医疗与药品信息工作。曾为EMBase和几家医药数据库担任文摘；多家期刊杂志（其中包括Lancet Infections Diseases and Lancet Oncology）新闻撰稿人；任Springer和Society for General Microbiology编辑。除编辑工作外，还帮助数家知名药业公司建立产品文献数据库。2005年加盟理文编辑，主要编辑医学和生命科学方面文章，尤其是微生物学和传染病学。是普通微生物学会会员。

Dr Kerr originally studied microbiology at Glasgow University and went on to complete a PhD on herpes viruses at Aberdeen University. He then specialized in electron microscopy and continued for a few years in post-doctoral research on ultrasound treatment of cancer. This was followed by a diploma in information studies, and he has worked in medical and drug information since 1991. Dr Kerr has worked previously as an indexer for EMBase and other pharmaceutical databases, a news writer for several journals including Lancet Infections Diseases and Lancet Oncology, and as a copyeditor for Springer and the Society for General Microbiology. In addition to editing, he works on product literature databases for a number of leading pharmaceutical companies. Dr Kerr joined the Edanz Group in 2005 and edits in the medical and life sciences, with a particular interest in microbiology and infectious diseases. He is a member of the Society for General Microbiology.

医学和科学编辑/撰稿人，拥有为医疗机构和药品广告研究机构进行生命科学内容开发的经验。最初任加拿大蒙特利尔戴维斯夫人医学研究院癌症研究实验室研究助理，进行分子和细胞生物学实验，内容包括：mRNA、DNA和蛋白质提纯、Northern 和Western杂交、RT - PCR、细胞运输、原代组织培养、各种药物疗效研究。还撰写了期刊杂志的投稿和向资助机构提供的实验室文件。后又从事医药广告工作8年，负责校对、审稿和事实审查；撰写了医学教育计划（向医师和护理人员传授药品标签方面的知识）。同时还是经验丰富的医学与科学自由撰稿人和编辑，为各种研究实验室和企业实体供稿。于2009年开始为理文编辑工作，担任编辑。

Ms Malapetsas is a medical and scientific editor/writer with experience in the development of content in the various areas in the life sciences for both medical research institutes and pharmaceutical advertising agencies. Initially a research assistant in a cancer research laboratory at the Lady Davis Institute for Medical Research in Montreal, Canada, she performed molecular and cellular biology experiments—including mRNA, DNA, and protein extraction and purification, Northern and Western blots, RT-PCR, cellular transport, primary tissue culture, and various drug efficacy studies. She also developed laboratory documents for submission to journals and funding agencies. Ms Malapetsas then worked in pharmaceutical advertising, where for eight years she undertook proofreading, copyediting, and fact-checking, and wrote medical education programs delivering on-label drug information to physicians and healthcare professionals. Ms Malapetsas also has extensive experience as a freelance medical and scientific editor/writer for research laboratories and corporate entities. Ms Malapetsas began working as an editor with the Edanz Group in 2009.

Brunker 女士具有二十余年生物医学领域稿件的编辑经验，包括向同行评审期刊投稿的文章、学位论文和学术文章、向美国监管机构（食品和药品管理局以及美国专利商标局）递交的申请材料；各种药物广告、网站内容、演讲稿、论文以及会议等场合所需的材料；同时还包括广泛的医学教学资料。她的硕士学位论文探讨了HIV+ CD4+ 细胞的凋亡。还曾参与过乳癌和环境医学的实验室工作。

Ms Brunker has been editing biomedical documents for over two decades, including submissions to peer-reviewed journals, dissertations and other academic papers, applications to US regulatory agencies (the Food and Drug Administration and the Patent and Trademark Office), pharmaceutical advertisements of all types, Web site content, slide presentations, scripts and other support pieces for conferences and similar events, and a wide variety of medical education materials. Her master’s thesis was on apoptosis in HIV+ CD4+ cells. She has also done laboratory work in breast cancer and environmental medicine.

Dr Dawes的博士研究课题是视网膜神经保护药物以及对视网膜缺血的影响。攻读博士之前，就已在伦敦国家医学研究院任高级研究助理长达15年，从事两栖类视觉系统中视神经可塑性的研究。此后开始在伦敦St Bartholomew医院医学院研究，研究经全身照射后食物抗氧化剂对动物组织中形成的脂质过氧化物的作用。参与了15篇同行评审论文的写作，曾在国家和国际科学会议上发言。专业经验涵盖：辐射生物学、生物化学、解剖学、组织学、神经生理学和神经药理学。在研究工作的同时，38年来一直任英国开放大学助教，讲授神经生物学、心理学和基础科学。现从事英国与中国的交流，自2010年起开始在理文编辑担任编辑。

Dr Dawes’ PhD focused on neuroprotective drugs and their effects on retinal ischemia. Before undertaking her PhD, Dr Dawes spent 15 years as a senior research assistant at the National Institute for Medical Research, London, studying neuronal plasticity in the amphibian visual system. Dr Dawes’ then began research at St Bartholomew’s Hospital Medical School, London, studying the effects of dietary antioxidants on lipid peroxide formation in animal tissue after whole body irradiation. She has been an author on 15 peer reviewed papers and has given presentations at national and international scientific meetings. Dr Dawes’ experience has covered techniques in radiation biology, biochemistry, anatomy, histology, neurophysiology and neuropharmacology. Concurrent with her research, for 38 years Dr Dawes has been an assistant lecturer at the Open University, UK, teaching neurobiology, psychology and foundation sciences. Dr Dawes now works between the UK and China, and began working as an editor with the Edanz Group in 2010.

科技与医学作家，编辑经验涉及广泛的医学和生命科学领域。硕士论文涉及抗微生物制剂的开发，用以防治抗药性细菌。曾执教于North Carolina-Greensboro大学，讲授生物学和微生物学，同时还研究肥胖、炎症、胰岛素抵抗之间的联系。曾与他人合作撰写了7份在同行评审期刊上发表的科技文章以及一篇专书论文。持有生物医学研究生写作证书，是生命科学认证编辑（ELS）。作为编辑，编辑了数以百计的研究文章；作为作家，为药业和生物技术业编写了有关健康与医疗的文章。自2010年起为理文编辑工作，担任编辑。

Ms LaPoint is a science and medical writer-editor with experience in a wide range of medical and life science topics. Her master’s thesis involved the development of antimicrobial agents to prevent and treat antibiotic-resistant bacteria. Ms LaPoint has taught biology and microbiology at the University of North Carolina-Greensboro, where she also conducted research investigating links between obesity, inflammation, and insulin resistance. She has co-authored seven scientific manuscripts published in peer-reviewed journals and one scientific book chapter. Ms LaPoint also has a post-graduate biomedical writing certificate and is a board-certified editor in the life sciences (ELS). As an editor she has edited hundreds of research manuscripts, as a writer she has written about health and medical topics for the pharmaceutical and biotechnology industries. She began working as an editor and writer with the Edanz Group in 2010.

Dr Rogers目前任瑞士日内瓦大学科学交流与写作讲师，此前曾任生物技术行业的一个研究实验室主任一职，专门从事蛋白质组学研究，同时还从事食品行业内的初级材料研究。在巴黎大学从事博士后研究，并作为皇家学会研究员在苏塞克斯大学从事研究。发表的文章内容广泛，是七份生物技术专利的联合撰稿人。于2010年开始在理文担任编辑。

Dr Rogers presently is a lecturer in scientific communication and writing at the University of Geneva, Switzerland. He has previously held research positions as a laboratory head within the biotechnology industry, specializing in proteomics research, and within the food industry, conducting research in primary materials. He completed post-doctoral research within the University of Paris, as a Royal Society Fellow, and at the University of Sussex. He has published widely and is joint author to seven biotechnology patents. Dr Rogers began working as an editor for the Edanz Group in 2010.

Hackett女士从事科学期刊编辑工作15年，最初在Elsevier Science出版公司旗下的Current Science期刊从事科学出版工作，。1997至2007年间，在极具影响力的评审期刊Current Opinion in Structural Biology独挑管理与编辑大梁。2002年，出任Current Opinion生命科学评审期刊选集责任编辑，在Elsevier药物发现小组内部组织评审期刊精选活动。在出版公司担任编辑期间，还曾为Trends in Biochemical Science、Trends in Pharmacological Science、Trends in Cell Biology、International Journal of Infectious Diseases、Development和Drug Discovery Today担任文章编辑。现为全职撰稿人和编辑顾问。于2009年开始为理文编辑工作，担任编辑。

Ms Hackett has been a science journal editor for 15 years, beginning her science publishing career in the Current Science group, which became part of Elsevier Science. Between 1997 and 2007, she had sole responsibility for managing and editing the high-impact review journal Current Opinion in Structural Biology. In 2002, Ms Hackett became Managing Editor of the portfolio of Current Opinion life science review journals and helped launch a collection of review journals within Elsevier’s Drug Discovery group. During her publishing career as an editor, Ms Hackett has edited articles for Trends in Biochemical Science, Trends in Pharmacological Science, Trends in Cell Biology, the International Journal of Infectious Diseases, Development, and Drug Discovery Today. She now works as a full-time publishing and editorial consultant. Ms Hackett began working as an editor for the Edanz Group in 2009.

Featured Editor

Specialist in Veterinary medicine

6年外科医学和动物医学经验，目前的工作身份是美国全科医师。Dr Morben在编辑和校对各种科研文章上丰富经验。美国医学作家协会成员。2010年起为理文编辑工作，担任编辑。

Dr Morben has six years of experience in veterinary medicine. She currently works as a general practitioner in the United States. In addition, Dr Morben has extensive experience editing and proofreading a wide variety of research manuscripts and is a member of the American Medical Writers Association. Dr Morben began working as an editor with the Edanz Group in 2010.

Featured Editor

Research interests: neurological mechanisms of time and rhythm perception, motor rhythm synchronization and therapeutic brain stimulation

Koke女士目前在美国加利福利亚北部达勒姆市杜克大学心理与神经科学系攻读博士。研究领域包括：时间和节奏感知、运动节奏同步和治疗性脑部刺激的神经学机制。之前，曾是卡尔加里大学行为神经科学研究小组的一名研究助理，之后在霍奇基斯脑科研究所多个研究实验室工作，研究领域包括癫痫症、生理节奏、学习与记忆以及治疗性脑部刺激。拥有啮齿动物和灵长类动物行为训练和立体定向手术方面的经验。Koko女士拥有5年从事行为神经科学和临床神经科学的研究经验，曾在国际同行评审期刊上发表过两篇论文。2010年加盟理文编辑，担任编辑。

Ms Koke is presently in the Psychology and Neuroscience PhD program at Duke University in Durham, North Carolina, U.S.A. Her research interests include the neurological mechanisms of time and rhythm perception, motor rhythm synchronization and therapeutic brain stimulation. Previously, Ms. Koke worked as a research associate at the University of Calgary in the Behavioural Neuroscience Research Group and then as a member of the Hotchkiss Brain Institute in various research labs, studies included epilepsy, circadian rhythms, learning and memory, and therapeutic brain stimulation. She has experience with behavioral training and stereotaxic surgery in both rodent and primate models. Ms Koko has 5 years of research experience in the fields of behavioral neuroscience and clinical neuroscience, publishing two papers in international peer-reviewed journals. Ms Koke joined the Edanz Group as an editor in 2010.

Wallace先生的专业背景是生物化学和遗传学。后曾从事生物医学和生物工程研究，特别是周围神经系统和中枢神经系统的神经再生。博士期间的研究主要涉及脊髓损伤的组织工程学，结合采用新型神经导管作为细胞载体，促使神经系统轴突再生。该项目还研究了对神经干细胞采取最佳的细胞分离方法，利用水凝胶优化神经导管。在以下领域经验丰富：组织提取和细胞培养、病毒转导、电纺丝、扫描电子显微镜、荧光显微镜、骨架冻干处理、骨胶原分离、RT-PCR、SDS-PAGE、核酸杂交技术和组织学。2004–2006年期间，曾作为科学信息专家，服务于Thomson Scientific & Healthcare。期间，负责分析已发表的生命科学和生物医学文章并从中筛选所需信息，从而实现与Web of Science数据库约8,700种知名研究杂志中的多学科信息的无缝对接。曾作为BIOSIS Previews质量控制小组成员，负责撰写科学文章摘要。2009年加入理文编辑，从事编辑工作。

Mr Wallace’s background is in biochemistry and genetics. Later he focused on biomedical science/bioengineering, in particular nerve regeneration in both the peripheral and central nervous systems. His PhD focuses on tissue engineering for spinal cord injury and combines the use of novel nerve guides as cell carriers for the promotion of axonal regeneration. This project also looks at optimal cell isolation protocols for neural stem cells and optimization of nerve conduits using hydrogels. He is experienced in tissue extraction and cell culture, viral transduction, electrospinning, scanning electron microscopy, fluorescence microscopy, freeze-dry processing of scaffolds, collagen isolation, RT-PCR, SDS-PAGE, Southern blotting and histology. He has also worked as a Scientific Information Specialist for Thomson Scientific & Healthcare during 2004–2006. In this position he was responsible for analyzing and extracting information from life science and biomedical articles to allow for seamless access to current and retrospective multidisciplinary information from approximately 8,700 high-impact research journals from the Web of Science. He also worked as part of the quality control team for BIOSIS Previews, where he was required to write abstracts for scientific articles. Mr Wallace began working as an editor for the Edanz Group in 2009.

Dr Barrett的博士论文题目是“低温治疗以及在早产绵羊上的效果”，博士后研究主要集中在胎儿生理和神经科学领域。Dr Barrett拥有大型动物和胎儿外科手术方面的经验，包括导管与电极置放、动物屠宰后解剖。另外还擅长对体内电生理数据的分析，包括：癫痫发作脑电图、温度、肌电图、心电图、血压和血流量图等。曾接受过系统生理学培训，对复杂而独特的心血管和中枢神经系统反应有深入的理解。组织学领域的经验包括：脑组织的体视学方法染色与分析、相关的显微镜技术。已在多家同行评审期刊上发表文章，与人合作撰写了一篇专书论文，多次出席国家级和国际级学术会议。2011年开始供职理文，担任编辑一职。

Dr Barrett’s PhD thesis was entitled “Therapeutic hypothermia and its effects on the preterm fetal sheep”. His post-doctoral research focuses on fetal physiology and neuroscience. Dr Barrett has experience in large animal and fetal surgery techniques, including catheter and electrode placement and animal post-mortem dissections. Dr Barrett is also skilled in analysis of electrophysiological data in vivo, including EEG seizure activity; temperature, ECG, EMG, blood pressure and blood flow. He has training in systems physiology, as well as an understanding of the complex and unique cardiovascular and central nervous system responses. Dr Barrett’s histology skills include, stereological staining and analysis of brain tissue, and associated microscope skills. Dr Barrett has published papers in peer reviewed journals, co-authored a book chapter and presented at national and international congresses. Dr Barrett began work as an editor for the Edanz Group in 2011.

Featured Editor

Pharmacologist with expertise in molecular pharmacology, signal transduction, and neuroscience

Dr Price接受过药理师培训，主要专业是分子药理学、信号传导和神经科学。对促进神经再生的化合物免疫亲和蛋白进行了大量研究。曾在日本、美国和欧洲的医药品和小型生物技术公司工作。发表了20多篇研究文章，其中包括邀稿评审。在过去7年里，已编辑和合作编写了1100多篇科学出版物、发言演示稿和规范性文件。于2008年开始为理文编辑工作，担任编辑。

Dr Price's training is as a pharmacologist, with specific emphasis on molecular pharmacology, signal transduction, and neuroscience. His research includes extensive work on immunophilins, a class of compounds that promote nerve regeneration. He has worked in both pharmaceutical and small biotechnology companies in Japan, the US, and Europe. He has published over 20 research articles, including an invited review. Over the past seven years, Dr Price has edited/co-written over 1100 scientific publications, presentations, and regulatory documents. Dr Price began as an editor with the Edanz Group in 2008.

Dr James的博士论文以及最初的博士后工作内容，是研究精神疾病易感基因DISC1的表征。之后的博士后研究主要集中在急性颅脑损伤和转基因小鼠模型线粒体反应。Dr James研究大脑生物学，尤其对精神疾病、神经退行性疾病、遗传学和细胞生物学有浓厚的兴趣。拥有多学科实验室专业知识，涵盖蛋白质生物化学、细胞和分子生物学、组织学和显微镜技术。Dr James在人体组织研究、以及转基因动物模型和细胞培养系统（包括胚胎干细胞）方面经验丰富。基于研究工作，她与人合作撰写了多篇同行评审论文，包括《科学》杂志的一篇论文，该项研究被誉为2005年十大突破之一。2011年加盟理文编辑，担任编辑工作。

Dr James’ PhD thesis, and initial postdoctoral work, was on the characterization of DISC1, a susceptibility gene for psychiatric illness. Subsequent postdoctoral research focused on acute brain injury and the mitochondrial response in a transgenic mouse model. Dr James understands brain biology with a particular interest in psychiatric illness, neurodegenerative disease, genetics and cellular biology. She has multi-disciplinary laboratory expertise in a number of techniques, covering protein biochemistry, cellular and molecular biology, histology and microscopy. Dr James has experience of human tissue studies, as well as transgenic animal models and cell culture systems, including embryonic stem cells. From her research she has co-authored several peer-reviewed papers, including a Science paper, which was cited as one of the top ten breakthroughs of 2005. Dr James joined the Edanz Group as an editor in 2011.

Featured Editor

Has edited and/or authored over 200 publications in textbooks and top-tier peer-reviewed journals, including the American Journal of Clinical Nutrition, Nature, Journal of the American Dietetic Association, Journal of Nutrition, and Nature Cardiovascular

作为获奖医学作家，拥有13年为全球主要权威机构撰写、编辑文章的丰富经验，涉及领域包括糖尿病、肥胖症、心血管病、高血压、癌症、营养学、减肥手术、产科、流行病学、公共卫生和微创手术。擅长对即将出版的原稿进行综合处理，包括撰写、编辑和校对，已编辑和撰写了200多件出版物。作品已选入教科书并刊登在一流同行评审期刊上，如“American Journal of Clinical Nutrition”、自然、Journal of the American Dietetic Association、Journal of Nutrition和Nature Cardiovascular。仅用3年时间便以最优异的成绩从美国马萨诸塞州波士顿大学毕业，获传播学学位。近期编辑了由Frank B. Hu（医学博士、哲学博士，哈佛大学公共卫生学院营养学与流行病学教授、哈佛波士顿医学院医学教授）所著《肥胖流行病学》（Obesity Epidemiology），由牛津大学出版社出版。2010年加盟理文编辑，担任编辑和撰稿人。

Ms Buckley is an award-winning medical writer with 13 years of experience writing and editing for some of the world’s leading authorities in the fields of diabetes, obesity, cardiovascular disease, hypertension, cancer, nutrition, weight loss surgery, obstetrics, epidemiology, public health, and minimally invasive surgery. She specializes in the delivery of publication-ready manuscripts being involved in a combination of writing, editing, and proofreading services. Ms Buckley has edited and/or authored over 200 publications. Her work has been published in textbooks and top-tier peer-reviewed journals, including the American Journal of Clinical Nutrition, Nature, Journal of the American Dietetic Association, Journal of Nutrition, and Nature Cardiovascular. Ms Buckley graduated summa cum laude in three years from Boston University (Boston, MA, USA) with a degree in Communications. She recently edited Obesity Epidemiology (Oxford University Press) by Frank B, Hu, M.D., Ph.D., Professor of Nutrition and Epidemiology, Harvard School of Public Health, Professor of Medicine, Harvard Medical School (Boston, USA). Ms Buckley joined the Edanz Group as an editor and writer in 2010.

夸祖鲁纳塔尔大学实验室医学与医学科学学院人体生理系副教授,并在健康科学学院和纳尔逊曼德拉医学院教授人体生理学和人类遗传学，同时还负责基因表达实验室的运作。研究重点：高血压病以及利用药用植物进行控制高血压；先兆子痫的病因与治疗。Mackraj教授的博士后研究工作内容是基因突变近肾端小管细胞模型的生成与表征，用于肾转运机制的研究。目前的研究项目是：降血压植物的研究（重点是血管紧张素系统）、先兆子痫和当地人群的发病机制。另外，还参与了一些新药输送系统的研究项目。经常在ISI列表刊物上发表作品，是多个研究项目基金的主要获奖人。Mackraj教授2011年加盟理文编辑，担任编辑和专家评审。

Prof Mackraj is an Associate Professor in the Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of Kwazulu-Natal. She teaches Human Physiology and Human Genetics at the Faculty of Health Sciences and the Nelson R Mandela School of Medicine. She is responsible for running a gene expression laboratory. Her main research focuses are hypertension and its management using medicinal plants; and the etiology and treatment of pre-eclampsia. Prof Mackraj’s postdoctoral work involved the generation and characterization of a gene-disrupted proximal tubular cell model for the investigation of transporter mechanisms in the kidney. Her current research projects involve the investigation of blood pressure lowering plants with a focus on the renin-angiotensin system; and the etiopathology of pre-eclampsia in the local population. She is also a participant in projects involving novel drug delivery systems. She is a well-published author in ISI-listed journals, and is the Principle grant-holder for her research projects. Prof Mackraj joined the Edanz Group as an editor and reviewer in 2011.

Dr Eve McCutchen Vick的研究内容包括：海马突触可塑性、海马胆碱能神经支配的变性、神经营养因子对神经信号的调制等。专业经验包括：学习与记忆、突触可塑性、海马生理学与细胞内信号、胆碱与肾上腺素受体、电生理和免疫组化。曾在高水平刊物上发表文章，编辑的稿件跨越了多个学科：神经科学、药理学、毒理学和心脏病学。另外还在美国多家院校讲授心理学和解剖生理学本科课程。2011年加盟理文编辑，担任编辑。

Dr Eve McCutchen Vick’s research has included studies of hippocampal synaptic plasticity, degeneration of hippocampal cholinergic innervation, and modulation of neuronal signaling by neurotrophic factors. Her expertise includes learning and memory, synaptic plasticity, hippocampal physiology and intracellular signaling, cholinergic and adrenergic receptors, electrophysiology and immunohistochemistry. Dr Vick is well published in high-ranking journals, and has edited manuscripts across a variety of subject areas, including neuroscience, pharmacology, toxicology, and cardiology. She has also taught undergraduate courses in both Psychology and Anatomy and Physiology at several institutions in the US. Dr Vick joined the Edanz Group as an editor in 2011.

O’Neill女士是一位拥有广泛专业知识的信息科学资深专家，所涉领域包括：制药学、药物学、药理学、普通内科、生物化学、分子生物学、保健管理和环境生物学等。从1993年到2007年，为数家知名药业公司工作，从事EMBASE数据库、BIOSIS 数据库和定制药物数据库的专业化医疗文摘索引。在写作定向药业文摘方面经验丰富。2007年起成理文编辑的一名编辑，与此同时，目前仍在一些大型制药公司从文摘事索引工作，主要涉及药理学和肠胃病等领域。

Ms O’Neill is a highly proficient information scientist and indexer with extensive experience in a wide range of disciplines, including pharmaceutics, pharmacy, pharmacology, general medicine, biochemistry, molecular biology, health care management and environmental biology. From 1993 to 2007, Ms O’Neill was a specialist medical indexer working on the EMBASE database, BIOSIS database and customized drug-based databases for a number of leading pharmaceutical companies. She is also experienced at writing customized abstracts for the pharmaceutical industry. Ms O’Neill began working as an editor with Edanz Editing in 2007. As well as the work carried out for Edanz, Ms O’Neill is currently still performing indexing work, mainly in the fields of pharmacology and gastroenterology, for a variety of major drug companies.

Dr Eastman拥有大量临床护理经验。1977年获American Board of Family Practice认证，1981年获American Board of Emergency Medicine认证，一直从事护理培训和应急护理规划。Dr Eastman一直是美国联邦航空局资深航空体检师、汽艇竞赛安全顾问和医疗事故鉴定专家。曾于1986年出任美国家庭医师医学会加州橙县分会主席。1992年，加入新西兰乡村家庭医生项目，领导开发了计算机化数据库和X射线治疗项目。曾为卫生保健专栏撰稿人，发表过多篇医学伦理学文章。于2011年加入理文编辑。

Dr Eastman has wide clinical care experience. He was board certified by the American Board of Family Practice in 1977 and by the American Board of Emergency Medicine in 1981. He has been involved in paramedic training and emergency care planning. Dr Eastman has been a Federal Aviation Administration Senior Aviation Medical Examiner, a safety advisor for power boat racing and an expert witness in cases of alleged malpractice. In 1986 he was president of the Orange County (California) chapter of the American Academy of Family Practitioners. In 1992 Dr Eastman joined a rural general practice in New Zealand, leading development of its computerized database and of X-ray services. He has written a health care column and has published on medical ethics. Dr Eastman joined the Edanz Group as an editor in 2011.

Igelstrom 女士现任奥塔哥大学电生理学研究人员，拥有生物化学和生理学专业背景，现从事神经科学专业。她的博士研究内容主要是癫痫发作的脑片模型，目前正在研究抗癫痫药物治疗中采用的离子通道调制剂。在电生理技术领域经验丰富，其中包括全细胞电压/电流钳，细胞贴附式密封电流钳，场电位记录，单细胞电位记录等。以往和目前的研究范围：行为激励制约，嗅觉处理，非突触神经递质，癫痫发作，抗癫痫药物，抗抑郁药物等。Igelstrom女士还对替代疗法/补充疗法的生理作用有着浓厚的兴趣，如中医和瑜伽。除了在电生理学领域的经验外，Igelstrom女士还拥有细胞培养、免疫印迹、显微镜技术、大鼠行为训练和免疫组化等方面的经验。Igelstrom 女士2011年加盟理文编辑，担任编辑。

Ms Igelstrom currently works as an electrophysiologist at the University of Otago. She has a background in biochemistry and physiology, and is now specializing in neuroscience. Her PhD research focused on brain slice models of epileptic seizures, and she is currently investigating ion channel modulators for antiepileptic drug treatment. She has experience with a variety of electrophysiological techniques, including whole-cell voltage/current clamp, cell-attached tight-seal current clamp, field potential recording, and single-unit recording. Her past and current research interests include behavioral reward conditioning, olfactory processing, non-synaptic neurotransmission, epileptic seizures, antiepileptic drugs, and antidepressant drugs. Ms Igelstrom also has a special interest in the physiological effects of alternative and complementary therapies, such as Chinese medicine and yoga. Apart from her electrophysiological skills, Ms Igelstrom also has experience with cell culture, western blotting, microscopy, behavioral rat training, and immunohistochemistry. Ms Igelstrom joined the Edanz Group as an editor in 2011.

Featured Editor

Edited more than 3,000 manuscripts for Japanese authors

Dr Sherwin的专业背景是生物化学，主攻骨关节炎、组织工程和细胞培养。积累了细胞和分子生物学技术方面的大量经验，写作经验丰富，在英国和新西兰博士后工作期间，作为第一作者和辅助作者发表了大量同行评审期刊文章和科学报告。2002年起成为理文编辑的全职编辑，已为日本作者编辑了3000多篇用于研究领域的文章和有关生命与健康的期刊投稿。

Dr Sherwin’s scientific background is in biochemistry with an emphasis on osteoarthritis, tissue engineering and cell culture. She has wide experience in both cell and molecular biology techniques. Dr Sherwin has excellent writing skills and has published several peer-reviewed journal articles and scientific reports as both lead author and supporting author during her post-doctoral work in the United Kingdom and New Zealand. Dr Sherwin has been a full-time editor with Edanz Editing since 2002. During that time, she has edited over 3000 manuscripts in the Health and Life Sciences for Japanese and Chinese authors, with a wide range of research fields and target journals.

Featured Editor

Expert in the molecular genetics of psychiatric illness

Patel是一名神经科学家，专注于中枢神经系统退化和精神疾病的研究。在博士课题下，他开发了一个小鼠基因剔除模型，用于人类脑神经紊乱失调铜蓝蛋白缺乏症的研究。之后在哈佛大学医学院细胞生物学系担任研究员，研究神经细胞迁移中的分子信号通路。Patel近期一直在蒙特利尔道格拉式心理健康研究所担任助理，专注于精神疾病分子基因的研究。研究重点是严重抑郁症和自杀中的 microRNA信号网络microRNA的信令网络参与严重抑郁症和自杀。以第一作者的身份在很多有影响力的期刊上发表了多篇文章，包括《生物化学期刊》和《神经科学期刊》。2011年开始在理文编辑从事编辑工作。

Dr Patel is a neuroscientist interested in central nervous system degeneration and mental illness. For his doctoral thesis he developed a mouse gene-knockout model for the human neurological disorder aceruloplasminemia. Subsequently, as a research fellow at the Department of Cell Biology at Harvard Medical School he studied the molecular signaling cascades involved in nerve cell migration. Dr Patel has recently focused his research on the molecular genetics of psychiatric illness as an associate at the Douglas Mental Health Institute in Montreal. His studies center on microRNA signaling networks involved in major depression and suicide. Dr Patel has published a number of first-author articles in high-impact journals, including The Journal of Biological Chemistry and The Journal of Neuroscience. He began editing for the Edanz Group in 2011.

Dr Donkin的博士论文题目是“神经肽P物质对大鼠创伤性脑损伤后果的作用”。研究兴趣还包括利用啮齿动物模型开发用于治疗脑外伤和神经退行性疾病的新药物治疗剂。已完成在加拿大不列颠哥伦比亚大学的博士后研究，研究在预防和治疗阿尔茨海默氏病中采用防治化合物的可能性。Dr Donkin已发表多篇同行评审期刊文章，目前的职业是科研作家。2011年加入理文，担任科技编辑、撰稿人和审稿人。

Dr Donkin's PhD thesis was entitled "The Effects of the Neuropeptide Substance P on Outcome Following Traumatic Brain Injury in Rats". His research interests include developing novel pharmacotherapeutic agents for the treatment of neurotrauma and neurodegeneration using rodent animal models. He has completed a post-doctoral fellowship at the University of British Columbia, Canada, investigating potential prophylactic and therapeutic compounds in the prevention and treatment of Alzheimer's disease. Dr Donkin has published several peer-reviewed journal articles and currently works as a scientific writer. Dr Donkin joined the Edanz Group as a science editor, writer and reviewer in 2011.

Featured Editor

Specialist biomedical writer

协助撰稿人撰写国际医学刊物投稿已有22年历史。最初于1988年为W.B. Saunders Company (Elsevier) 工作，一开始担任制作编辑，很快晋升为期刊部业务经理。1993年起转做自由职业编辑，在医学交流、出版和广告领域为客户提供帮助。为客户撰写和开发了一系列生物医学材料，包括科学海报、摘要、幻灯集、专论、档案、竞争力分析、专题文章、处方集、出版计划、CME/USMLE材料、作者简介、网站内容和产品培训材料等。工作内容涵盖大多数治疗领域，如肿瘤科、心脏科、内分泌科、神经科、外科、药理、数字成像和疼痛控制。Ms Seminara是美国医学作家协会会员，并任International Scleroderma Network高级编辑。此外，还是Senior Sez Games的创办者，向患有不同程度阿尔茨海默氏病的人提供帮助。2010年加盟理文编辑，担任编辑和撰稿人。

Ms Seminara has helped authors prepare manuscripts for international medical journals for over 22 years. Her career began at W.B. Saunders Company (Elsevier) in 1988, where she started as a Production Editor, soon becoming the Operations Manager of the Journals Department. Since 1993, she has been a freelance editor helping clients in the fields of medical communications, publishing, and advertising. Ms Seminara also writes and develops for clients an array of biomedical materials, including scientific posters, abstracts, slide kits, monographs, dossiers, competitive analyses, feature articles, formulary kits, publication plans, CME/USMLE materials, author biographies, web content, and product training materials. She works across a multitude of therapeutic areas, including oncology, cardiology, endocrinology, neurology, surgery, pharmacology, digital imaging, and pain management. Ms Seminara is a Member of the American Medical Writers Association and serves as Senior Editor for the International Scleroderma Network. She is the creator of Senior Sez Games for senior citizens, which are appropriate for people in various stages of Alzheimer's disease. Ms Seminara joined the Edanz Group as an editor and writer in 2010.

Dr Hitchin，有机合成化学家，拥有8年多制药和精细化工行业经验，精于合成化学、药物化学和工艺研究与开发。博士学位的研究课题是多官能基化奎宁环的合成与应用。目前任职于英国癌症研究中心高级科学主任，该中心设于英国百德新癌症研究所，在那里他带领一组药物化学专家研究肿瘤药物的新靶点。Dr Hitchin还曾任肯特郡 Sandwich实验室辉瑞全球研究与开发项目的化学组组长，负责设计和实施所有治疗方面的综合战略（包括疼痛、肥胖和病毒学），取得了很大成功。此外，还曾在一家由美国FDA批准工厂从事C – GMP生产。已在同行评审期刊上发表过多篇文章。2011年加盟理文编辑，担任编辑。

Dr Hitchin is a synthetic organic chemist with over eight years of experience in the pharmaceutical and fine chemical industries. He is skilled in the areas of synthetic chemistry, medicinal chemistry and process research and development. Dr Hitchin’s PhD investigated the synthesis and application of poly-functionalized quinuclidine systems. He is currently a Senior Scientific Officer for Cancer Research UK at the Paterson Institute of Cancer Research in the UK, where he leads a team of medicinal chemists investigating novel drug discovery targets in oncology. Dr Hitchin has also worked as a Chemistry Group Leader for Pfizer Global Research and Development at the Sandwich laboratories in Kent, UK, where he was responsible for the successful design and implementation of synthetic strategies across therapeutic areas including pain, obesity and virology. Further to this, Dr Hitchin has worked providing c-GMP manufacture in an FDA approved facility. Dr Hitchin has published in several peer-reviewed journals. He joined the Edanz Group as an editor in 2011.

Featured Editor

Currently pursuing an MSc in Science Communication at Otago University, New Zealand.

Granville先生的研究工作包括大鼠海马立早基因表达，大量使用了引物设计和序列分析；凝胶电泳和量化PCR。另外，还研究科技传播学，主要攻非小说写作；研究19中至20世纪的科学史和理念，领域包括心理学、神经科学、药理学、生物化学、分子和细胞生物学。于2010年加盟理文编辑，担任编辑和撰搞人。

Mr Granville's research has included work on the expression of immediate early genes in the rat hippocampus, and involved extensive use of primer design and sequence analysis, gel electrophoresis, and quantitative PCR. He has also studied Science Communication specializing in non-fiction writing, and has studied the history and philosophy of science over a wide range of disciplines including psychology, neuroscience, pharmacology, biochemistry, and molecular and cell biology, focusing on developments from the late 19th to mid-20th centuries. He joined Edanz Group in 2010 as a science editor and writer.

Dr Zagami的主要研究领域是神经系统的正常发育和功能、以及神经系统疾病的异变过程。早期研究涉足运动神经元病肌萎缩性侧索硬化症（ALS）脊髓薄片器官型培养模式的开发。曾对肌萎缩性侧索硬化症中的两个过程 — 谷氨酸转运体功能和细胞死亡中神经兴奋性毒性和氧化应激的作用进行分析。主要专注于星形胶质细胞的研究及其在调节谷氨酸转运体中的作用、以及这些机制对运动神经的影响。Dr Zagami的博士后研究在加拿大麦吉尔大学蒙特利尔神经科学研究所完成，通过研究在神经元系亚类分化中以及其它神经领域的轴突靶向中发挥重要作用的蛋白质，从而深入了解某些脑干神经元群的发育。2011年加盟理文，担任编辑。

Dr Zagami's scientific research has focused on the study of the normal development and function of the nervous system and the aberrant processes underlying neurological diseases. Her early studies involved the development of an organotypic spinal cord slice culture model of the motor neuron disease amyotrophic lateral sclerosis (ALS). Dr Zagami's PhD studies examined the roles of excitotoxicity and oxidative stress, two processes implicated in ALS, on glutamate transporter function and cell death. Particular attention was focused on astrocytes and their role in regulating glutamate transporters, as well the effect of these mechanisms on motor neurons. Dr Zagami’s postdoctoral work at the Montreal Neurological Institute, McGill University, Canada, aimed to gain a better understanding of the development of certain brainstem neuronal populations by focusing on a protein with an important role in neuronal subtype specification and axon targeting in other areas of the nervous system. Dr Zagami joined the Edanz Group as an editor in 2011.

Bass女士是一名医学学术和临床研究撰稿人、编辑。自2007年起一直从事研究基金申请书撰写、书稿编辑工作，并担任加州大学圣迭戈分校实验室的项目经理，协助多个领域的研究者进行研究，其中包括：医院政策和质量改进、放射学、医用物理学、纳米技术、材料科学和基因组学等不同领域。Bass女士还编辑了一些有关病人教育和补充/替代医疗的指导手册，并担任圣地亚哥一家健康保险公司的新闻稿件编辑工作。除了学术学位以外，Bass女士还于2004年获得圣迭戈州立大学科技写作高级证书。2011年加盟理文编辑，担任编辑。

Ms Bass is a science writer and editor focused on academic medicine and clinical research. Since 2007, she has served as a grant writer, manuscript editor, and project manager for many UC San Diego laboratories, assisting investigators involved in such diverse fields as hospital policy and quality improvement, radiology, medical physics, nanotechnology, materials science, and genomics. Ms Bass has also edited patient-education and complementary/alternative medicine guidebooks and newsletters for a San Diego-based health insurer. In addition to her academic degrees, in 2004 Ms Bass earned an Advanced Certificate in Technical & Scientific Writing from San Diego State University. Ms Bass joined the Edanz Group as an editor in 2011.

Featured Editor

Expert in models and diagnosis of Parkinson's disease

Tinsley拥有南澳弗林得斯大学医学院博士学位。研究课题为“非病毒神经胶质细胞传染：中枢神经系统再生治疗战略”。博士后工作期间，在首位证明成年人大脑中神经形成的专家Peter Eriksson教授的神经干细胞实验室工作。之后重返澳大利亚，在霍华德•弗利研究所工作，研究帕金森氏疾病的模型和诊断。拥有十多年医学研究经验，曾在知名专业期刊发表作品，包括Annals of Neurology。2011年起为理文编辑工作，担任编辑。

Dr Tinsley completed his PhD at the School of Medicine at Flinders University of South Australia. His thesis title was "Non-Viral Glial Cell Transfection: A Therapeutic Strategy for CNS Regeneration." His post-doctoral training was in the neural stem cell laboratory of Prof Peter Eriksson, the first to demonstrate neurogenesis in the adult human brain. Dr Tinsley returned to Australia to work at the Howard Florey Institute, investigating models and diagnosis of Parkinson's disease. He has over ten years experience in medical research, and has published widely in leading journals in his field, including Annals of Neurology. Dr Tinsley began working as an editor with the Edanz Group in 2011.

职业经历

作为一名信息科学家，Smith 女士在生物医学和防御领域具有大量的科学写作经验，曾担任Thomson Scientific的生物医学编辑和索引编辑以及AWRE (英国原子武器研究院) 研究员，并曾在Defence Research Information Centre 的出版部门负责撰写和编辑防御领域相关的研究论文。除了在制药领域的经验外，Smith女士还在 Defence Nuclear Programme项目中熟练运用各种分析化学技术进行材料分析工作。Smith女士从2007年开始成为Edanz Editing 编辑一员。

Ms Smith is an information scientist with significant scientific writing experience in the biomedical and defence fields. She has been a biomedical editor and indexer for Thomson Scientific, and has worked as a scientific officer and researcher for the AWRE (Atomic Weapons Research Establishment, UK). She also managed the Defence Research Information Centre's publications section, writing and editing defence related research. As well as her experience in the pharmaceutical field, Ms Smith is proficient in using various analytical chemistry techniques to analyse materials used in the Defence Nuclear Programme. She began as an editor for Edanz Editing in 2007.